title: Exploring PLATO-USA paradox and CURRENT-OASIS 7 trials reveals the benefit of higher aspirin dose.
authors.affiliation: 1Wegmans Pharmacy, Ithaca, NY; 2HeartDrug Research, Johns Hopkins University, Towson, MD.
authors.forename: James J
authors.initials: JJ
authors.lastname: DiNicolantonio
authors.forename: Victor L
authors.initials: VL
authors.lastname: Serebruany
mesh_terms: D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000628:therapy*; D000241:Adenosine / Q000031:analogs & derivatives*; D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use*; D058919:Purinergic P2 Receptor Antagonists; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D010975:Platelet Aggregation Inhibitors; D058919:Purinergic P2 Receptor Antagonists; D000241:Adenosine; D013988:Ticlopidine; D001241:Aspirin